Sentinel lymph node biopsy in breast cancer: State of the art;Die sentinellymphknoten-entfernung beim mammakarzinom: Derzeitiger stand

Gynakologisch-geburtshilfliche Rundschau

Volumn 44, Issue 2, 2004, Pages 84-91

  Bauerfeind, Ingo ^a   Himsl, Isabelle ^a   Kühn, Thorsten ^b   Untch, Michael ^a   Hepp, Hermann ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Frauenkl Projektgruppe I ^*  (Germany)

Author keywords

Axillary lymph node excision; Axillary recurrence; Breast cancer; Lymphoscintigraphy; Sentinel lymph node

Indexed keywords

ADJUVANT THERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER SURGERY; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRITICAL PATHWAYS; FEMALE; GERMANY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 1842686094     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076861     Document Type: Article

References (54)

1. Engel J, Hölzel D, Kerr J: Epidemiologie; in Manual Mammakarzinome, Aufl 9. München, Tumorzentrum München/Zuckschwerdt, 2003, pp 1-11.
2. Silverstein M, Skinner K, Iomis T: Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-772.
3. Haid A, Kühn T, Konstantiniuk P: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 2002;28:705-710.
4. Cabanas R: An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
5. Morton A: A rational approach to the surgical management of melanoma. Ann Surg 1977;186:481-490.
6. Veronesi U, Salvadori B, Luini A: Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990;16:127-133.
7. Schwartz G, Giuliano A, Veronesi U, Consensus Conference Committee: Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, Philadelphia, April 2001.
8. Kennedy R, Kollias J, et al: Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 2003;90:1349-1353.
9. Borgstein P, Meijer S, Pijpers R, van Diest PJ: Functional lymphatic anatomy for sentinel node biopsy in breast cancer: Echoes from the past and the periareolar blue method. Ann Surg 2000;232:81-89.
10. Martin R, Berossis A, Fey J, et al: Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001;130:432-438.
11. De Cicco C, Cremonesi M, Luini A: Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080-2084.
12. Morita E, Chang J, Leong S: Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin North Am 2000;80:1721-1739.
13. Tafra L, Lannin D, Swanson M: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-59.
14. Resino M, Sanches Hermosa C: Preoperative lymphoscintigraphy to identify the sentinel lymph node in breast cancer. Rev Esp Med Nucl 2003;22:410-417.
15. Kühn T: Sentinel-node-biopsy beim Mammakarzinom. Geburtsh Frauenheilk 2003;63:835-840.
16. Czerniecki B, Scheff A, Callans L, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098-1103.
17. Chu K, Turner R, Hansen N: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-541.
18. Reynolds C, Mick R, Donohue J: Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-1726.
19. Viale G, Maiorano E, Mazzarol G, Veronesi U: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384.
20. Fahusen M, Ververs I, Vingerhoets A: Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-999.
21. Mignotte H, Treilleux I, Faure C: Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002;28:623-626.
22. Bakker X, Roumen R: Bleeding after excision of breast lumps. Eur J Surg 2002;168:401-403.
23. De Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T: Stage migration in breast cancer surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node. Eur J Surg Oncol 2003;29:216-220.
24. Veronesi U, Paganelli G, Viale G: A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553.
25. McMasters K, Wong S, Chao E, et al: Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg 2001;234:292-300.
26. Kim T: The Metaanalysis. ASCO and SABCS 2002 abstracts.
27. Boolbol S, Fey J, Borgen P: Intradermal isotope injection: A highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001;8:20-24.
28. Gatzemeier W, Orecchia R, Gotti G: Current status and future prospects report of experiences from the European Institute of Oncology (EIO). Strahlenther Onkol 2001;177:330-337.
29. Reitsamer R, Menzel C, Peintinger F: Sentinel lymph node biopsy in breast cancer patients results and experience after 500 sentinel lymphnode biopsies. Gynäkol Geburtshilfliche Rundsch 2003;43:98-103.
30. Giuliano R, Reintgen D, Cox C: Sentinel node biopsy in breast cancer: An overview. Breast J 2000;6:299-305.
31. Roumen R, Kuijt G, Liem I, van Beek M: Treatment of 100 patients with sentinel-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-1643.
32. Veronesi U, Galimberti V, Zurrida S, Pigatto F, et al: Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-458.
33. Chung M, Steinhoff M, Cady B: Clinical axillary recurrence in breast cancer patients after negative sentinel node biopsy. Am J Surg 2002;184:310-314.
34. Loza J, Colo F, Nadal J: Axillary recurrence after sentinel node biopsy for operable breast cancer. Eur J Surg Oncol 2002;28:897-898.
35. Takei H, Kurosumi M, Tabei T, Inoue K, et al: Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node negative breast cancer patients. Oncol Rep 2003;10:833-837.
36. Blanchard D, Donohue J, Reynolds C: Relapse morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-487.
37. de Boer R, Hillen H, Roumen R: Detection treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 2001;8:118-122.
38. Quetin P, Cutuli B, Velten M: Lymphnode recurrence in breast cancer: Report of 1,119 cases of infiltrating cancer. Presse Méd 2001;30:996-1000.
39. Wright F, Walker J, Law CH, McCready DR: Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol 2003;10:1054-1058.
40. Galimberti V, Veronesi P, Arnone P: Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 2002;9:924-928.
41. Tanis P, Nieweg O, Valdes R: Impact of nonaxillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 2002;87:705-710.
42. van der Ent F, Kengen R, van der Pol H: Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001;234:79-84.
43. Carcoforo P, Basaglia E, Soliani G: Sentinel node biopsy in the evaluation of the internal mammary node chain in patients with breast cancer. Tumori 2002;88:5-7.
44. Sabel MS, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, Hayes DF, Chang AE, Pierce LJ: Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 2003;186:102-105.
45. Brady B, Faut J, Jones R: Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg 2003;185:114-117.
46. Nason K, Anderson B, Byrd D: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187-2194.
47. Stearns V, Ewing C, Slack R, Penannen M: Lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002;9:235-242.
48. Tafra L: The learning curve and sentinel node biopsy. Am J Surg 2001;182:347-350.
49. Julian T, Dusi D, Wolmark N: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002;184:315-317.
50. Cohen T, Allweis T, Freund H: Current controversies in sentinel lymph node biopsy for breast cancer. Breast 2003;12:163-171.
51. Fernandez A, Escobedo A, Benito E: Sentinel node localization in patients with non-palpable breast cancer. Nucl Med Commun 2002;23:1165-1169.
52. Breslin T, Cohen C, Sahin A: Sentinel lymph node biopsy in accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-3486.
53. National Surgical Adjuvant Breast and Bowel Project, Progress Report 1999, Pittsburgh, May 2000. www.nsabp.pitt.edu/B-27.htm
54. Piato J, Barros A, Pincerato K: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy: A pilot study. Eur J Surg Oncol 2002;29:118-120.